Follistatin-like 1 and its paralogs in heart development and cardiovascular disease
- PMID: 35867287
- PMCID: PMC11140762
- DOI: 10.1007/s10741-022-10262-6
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease
Abstract
Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels and a leading cause of death worldwide. Thus, there is a need to identify new cardiokines that may protect the heart from damage as reported in GBD 2017 Causes of Death Collaborators (2018) (The Lancet 392:1736-1788). Follistatin-like 1 (FSTL1) is a cardiokine that is highly expressed in the heart and released to the serum after cardiac injury where it is associated with CVD and predicts poor outcome. The action of FSTL1 likely depends not only on the tissue source but also post-translation modifications that are target tissue- and cell-specific. Animal studies examining the effect of FSTL1 in various models of heart disease have exploded over the past 15 years and primarily report a protective effect spanning from inhibiting inflammation via transforming growth factor, preventing remodeling and fibrosis to promoting angiogenesis and hypertrophy. A better understanding of FSTL1 and its homologs is needed to determine whether this protein could be a useful novel biomarker to predict poor outcome and death and whether it has therapeutic potential. The aim of this review is to provide a comprehensive description of the literature for this family of proteins in order to better understand their role in normal physiology and CVD.
Keywords: FSTL1; FSTL4; FSTL5; Heart failure; Inflammation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Conflict of interest
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11140762/bin/nihms-1997301-f0001.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11140762/bin/nihms-1997301-f0002.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11140762/bin/nihms-1997301-f0003.gif)
Similar articles
-
Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population.Heart Vessels. 2024 Jun;39(6):563-570. doi: 10.1007/s00380-024-02364-y. Epub 2024 Feb 21. Heart Vessels. 2024. PMID: 38381171
-
Follistatin-like 1 in Cardiovascular Disease and Inflammation.Mini Rev Med Chem. 2019;19(16):1379-1389. doi: 10.2174/1389557519666190312161551. Mini Rev Med Chem. 2019. PMID: 30864520 Review.
-
Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.Stem Cell Res Ther. 2019 Jan 11;10(1):17. doi: 10.1186/s13287-018-1111-y. Stem Cell Res Ther. 2019. PMID: 30635025 Free PMC article.
-
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E899-906. doi: 10.1073/pnas.1108559108. Epub 2011 Oct 10. Proc Natl Acad Sci U S A. 2011. PMID: 21987816 Free PMC article.
-
Follistatin-like 1: A dual regulator that promotes cardiomyocyte proliferation and fibrosis.J Cell Physiol. 2020 Sep;235(9):5893-5902. doi: 10.1002/jcp.29588. Epub 2020 Feb 3. J Cell Physiol. 2020. PMID: 32017077 Review.
Cited by
-
Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population.Heart Vessels. 2024 Jun;39(6):563-570. doi: 10.1007/s00380-024-02364-y. Epub 2024 Feb 21. Heart Vessels. 2024. PMID: 38381171
-
Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice.bioRxiv [Preprint]. 2023 Dec 22:2023.12.21.572738. doi: 10.1101/2023.12.21.572738. bioRxiv. 2023. Update in: PLoS Pathog. 2024 Jun 11;20(6):e1011915. doi: 10.1371/journal.ppat.1011915. PMID: 38187647 Free PMC article. Updated. Preprint.
References
-
- Shibanuma M, Mashimo J, Mita A et al. (1993) Cloning from a mouse osteoblastic cell line of a set of transforming-growthfactor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem FEBS 217:13–19 - PubMed
-
- Zwijsen A, Blockx H, Van Arnhem W et al. (1994) Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue. Eur J Biochem 225:937–946 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous